Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Ehsan Ghorani, James L. Reading, Jake Y. Henry, et al.
Nature Cancer (2020) Vol. 1, Iss. 5, pp. 546-561
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield, James L. Reading, Clare Puttick, et al.
Cell (2021) Vol. 184, Iss. 3, pp. 596-614.e14
Open Access | Times Cited: 675
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G. DiNatale, Fengshen Kuo, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 662-677.e6
Open Access | Times Cited: 279
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
Frank J. Lowery, Sri Krishna, Rami Yossef, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 877-884
Open Access | Times Cited: 271
Genetic and non-genetic clonal diversity in cancer evolution
James R. Black, Nicholas McGranahan
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 379-392
Closed Access | Times Cited: 227
Tumour burden and efficacy of immune-checkpoint inhibitors
Filippo Gustavo Dall’Olio, Aurélien Marabelle, Caroline Caramella, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 2, pp. 75-90
Closed Access | Times Cited: 214
The association between tumor mutational burden and prognosis is dependent on treatment context
Cristina Valero, Mark Lee, Douglas R. Hoen, et al.
Nature Genetics (2021) Vol. 53, Iss. 1, pp. 11-15
Open Access | Times Cited: 210
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Cancer Cell (2021) Vol. 39, Iss. 11, pp. 1497-1518.e11
Open Access | Times Cited: 185
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Yanshuo Chu, Enyu Dai, Yating Li, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1550-1562
Closed Access | Times Cited: 185
Analyzing high-dimensional cytometry data using FlowSOM
Katrien Quintelier, Artuur Couckuyt, Annelies Emmaneel, et al.
Nature Protocols (2021) Vol. 16, Iss. 8, pp. 3775-3801
Closed Access | Times Cited: 115
A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer
Sandra Tietscher, Johanna Wagner, Tobias Anzeneder, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 110
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 73
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 69
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
Joy A. Pai, Matthew D. Hellmann, Jennifer L. Sauter, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 776-790.e7
Open Access | Times Cited: 68
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada
Immunity (2023) Vol. 56, Iss. 10, pp. 2270-2295
Open Access | Times Cited: 50
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer
Katey S.S. Enfield, Emma Colliver, Claudia Lee, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1018-1047
Open Access | Times Cited: 27
Immune Escape Mechanisms in Non Small Cell Lung Cancer
Andrea Anichini, Valentina Perotti, Francesco Sgambelluri, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3605-3605
Open Access | Times Cited: 134
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Daniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1490-1507
Open Access | Times Cited: 100
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
Lorenzo Federico, Daniel J. McGrail, Salah-Eddine Bentebibel, et al.
Annals of Oncology (2021) Vol. 33, Iss. 1, pp. 42-56
Open Access | Times Cited: 85
Tracking Cancer Evolution through the Disease Course
Chris Bailey, James R. Black, James L. Reading, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 916-932
Open Access | Times Cited: 70
Deciphering the immunopeptidome in vivo reveals new tumour antigens
Alex M. Jaeger, Lauren Stopfer, Ryuhjin Ahn, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 149-155
Open Access | Times Cited: 66
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
Jeppe Sejerø Holm, Samuel A. Funt, Annie Borch, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 62
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
Bin Yang, Xiong Li, Wei Zhang, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100856-100856
Open Access | Times Cited: 49
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Shivan Sivakumar, Enas Abu‐Shah, David Ahern, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1776-1776
Open Access | Times Cited: 43
Tumor-intrinsic determinants of immunogenic cell death modalities
Samuel T. Workenhe, Jonathan Pol, Guido Kroemer
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment
Jianhong Zhang, Chengyang Song, Ye Tian, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top